The short version of research chemical fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-07-20 and is reviewed periodically as new material appears.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | SR9009; Stenabolic | Nickname is not a chemical name. |
| Typical analytical method | LC-MS/MS | Often with isotope-labeled internal standard. |
| Storage temperature | -20 °C | Desiccated and protected from light. |
| Solution stability | DMSO stock; avoid freeze-thaw | Store at -20 to -80 °C. |
| Regulatory status | Not approved; varies by country | May be restricted as research chemical. |
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
Thaçi emerged from the final diplomatic settlement as the leader of the strongest faction within a KLA rife with factionalism. He moved quickly to consolidate power, unilaterally naming himself prime minister within a provisional government and allegedly ordering the assassination of the leaders of rival armed factions.
The electric bath for high-voltage static induction Oudin coil, a high-voltage induction coil, in use around 1900 Faradic battery, a device to provide localised electric stimulation Pulvermacher's chain, a wearable electrochemical device mostly used by quacks, in use during the second half of the 19th century. Leyden jars, an early form of capacitor, for storing electricity Electrostatic generators of various sorts
== Television == Airwolf Danger Man, (Known as Secret Agent in the United States) I Led Three Lives – The first foray into mass culture dealing with the Cold War. I Spy (1965–68 US television series) Get Smart MacGyver The Man from U.N.C.L.E. Mission: Impossible Quatermass II Several episodes of Star Trek featured a futuristic version of the Cold War, in terms of the United Federation of Planets vs. The Klingon Empire and the Romulan Star Empire, analogs for the United States, the Soviet Union, and the People's Republic of China, respectively. "A Taste of Armageddon" also showed the concept of MAD in a war between opposing sides. Scarecrow and Mrs. King Ivan the Terrible 1976 sitcom The Rocky and Bullwinkle Show 1960s cartoon for children and adults where the villains are Boris and Natasha, who were both parodies of the Soviet spies. The Sandbaggers The Twilight Zone, a number of episodes of which depicted fallout shelters, such as the 1961 episode, The Shelter, produced as a social commentary on the Civil Defense push during the Berlin Crisis of 1961, and the 1987 Ronald Reagan era "Shelter Skelter". Twilight Zone episodes commenting on other aspects of the Cold War, and World Peace include the 1986 A Small Talent for War. The Transformers (TV series), including the fact that the two first seasons take place during the latter years of the Cold War, an episode, Prime Target directly refers to an event of the episode as The highest point of tension between United States and Soviet Union, since the Cuban Missile Crisis.
== Post summit == From 11 to 12 November 2025, the G7 Foreign Ministers' Meeting was held at Niagara-on-the-Lake, and joint statement was issued. The joint statement showed their consensus on Ukraine and Sudan, but stayed away from contentious issues like the US military strikes on boats in the Caribbean and trade. They are increasing the economic costs to Russia and exploring measures against those who finance Russia's war efforts. Also, they raised alarm over China's military buildup and reiterated their resolve to create an alternative to its dominance in critical mineral supplies, and reaffirmed the importance of a Free and Open Indo-Pacific based on the rule of law.
Sources: en.wikipedia.org
== Awards == 1998–2000, Basil O'Connor Scholar, March of Dimes Birth Defects Foundation 1998–2000, Beckman Young Investigators Award, Arnold and Mabel Beckman Foundation 1998–2001, New Investigator in the Pharmacological Sciences, Burroughs Wellcome Fund 2007, William E.M. Lands Lectureship, University of Michigan Medical School 2013, Fellow, American Association for the Advancement of Science 2016, ASBMB Award for Exemplary Contributions to Education, American Society for Biochemistry and Molecular Biology 2020, Mary Swartz Rose Senior Investigator Award, American Society for Nutrition
These independent courts found their existence threatened by warlords, necessitating cooperation which resulted in their unification by 2000. The Islamic Courts Union (ICU) was a broad-based organization comprising various courts with diverse goals, from national political ambitions to local dispute resolution and propagation of Islam. Due to Islam's central role in Somali society, the initiative gained significant popularity and acceptance, along with substantial financial support from the Somali business community, as it originated from the grassroots level, built legitimacy through religious solidarity, addressed local security concerns, and demonstrated a commitment to restoring public order.
White Castle is an American regional hamburger restaurant chain with about 345 locations across 13 states, with its greatest presence in the Midwest and New York metropolitan area. It was founded in 1921, in Wichita, Kansas. White Castle has been generally credited as the world's first fast food hamburger chain. It is known for its small, square hamburgers – commonly referred to as "sliders" – sold at low prices: five cents from their introduction while gradually increasing in price during the 1930s, with promotional coupons in the 1940s, offering five burgers for ten cents. In 2014, Time named the White Castle slider "The Most Influential Burger of All Time". The company's restaurant locations are white buildings decorated with a castle motif.
Sources: en.wikipedia.org
Caffeine is a stimulant compound belonging to the xanthine class of chemicals naturally found in coffee, tea, and (to a lesser degree) cocoa or chocolate. Caffeine is included in many soft drinks, as well as a larger amount in energy drinks. It is the world's most widely used psychoactive drug and by far the most common stimulant. In North America, 90% of adults consume caffeine daily. A few jurisdictions restrict the sale and use of caffeine. In the United States, the Food and Drug Administration has banned the sale of pure and highly concentrated caffeine products for personal consumption, due to the risk of overdose and death. The Australian Government has announced a ban on the sale of pure and highly concentrated caffeine food products for personal consumption, following the death of a young man from acute caffeine toxicity. In Canada, Health Canada has proposed to limit the amount of caffeine in energy drinks to 180 mg per serving, and to require warning labels and other safety measures on these products. Caffeine is also included in some medications, usually for the purpose of enhancing the effect of the primary ingredient, or reducing one of its side effects (especially drowsiness). Tablets containing standardized doses of caffeine are also widely available. Caffeine's mechanism of action differs from many stimulants, as it produces stimulant effects by inhibiting adenosine receptors. Adenosine receptors are thought to be a large driver of drowsiness and sleep, and their action increases with extended wakefulness.
He worked as a music journalist and ran a magazine publishing business, launching Flexipop magazine in 1980 with ex-Record Mirror journalist Barry Cain. Robin Lustig (born 30 August 1948, London); was foreign correspondent in Madrid for Reuters; worked for The Observer as editor and Middle East correspondent; also presented The World Tonight, Newsstand, Stop Press, and File on 4 for Radio 4, and Newshour on the BBC World Service; presented programme covering sudden death of Diana, Princess of Wales, hours after announcement was made; also presented Talking Point (later renamed Have Your Say) for BBC World Service, BBC World TV; guests included Nelson Mandela, Thabo Mbeki, Olusegun Obasanjo, Hugo Chávez and Tony Blair; later worked on The World Tonight and Newshour; for BBC World Service, has presented every UK election night programme since 1997 as well as United States presidential election programmes; reported on elections in Iran, Israel, Japan, Russia and Zimbabwe; presented The World Tonight from Afghanistan, China, Iran, Iraq, Japan, Kosovo and Mexico; was awarded Gold Medal at the New York Radio Festival and broadcast live from Moscow on last day of Soviet Union; in 1998, won Sony Silver Award; was described in The Times as "arguably the best news presenter anywhere in radio after John Humphrys"; received Charles Wheeler award for outstanding contribution to broadcast journalism.
== External links == Academy of Managed Care Pharmacy American College of Clinical Pharmacy Board of Pharmacy Specialties Journal of Clinical Pharmacy and Therapeutics The British Journal of Clinical Pharmacy United Kingdom Clinical Pharmacy Association Clinical Pharmacy Education, Practice and Research
Eluxadoline, sold under the brand names Viberzi and Truberzi, is a medication taken by mouth for the treatment of diarrhea and abdominal pain in individuals with diarrhea-predominant irritable bowel syndrome (IBS-D). It was approved for use in the United States in 2015. The drug originated from Janssen Pharmaceutica and was developed by Actavis.
Sources: en.wikipedia.org
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.
Solid material is usually kept at -20 °C, desiccated, and protected from light. Dimethyl sulfoxide stocks should be stored cold and subjected to minimal freeze-thaw cycles. Aqueous solutions are generally less stable and should be prepared fresh when possible.
Legality depends on the country and the intended use. It is not an approved medicine, and some places restrict or ban sales for human consumption. Buyers should verify local rules and product documentation before procurement.
SR9009 is a synthetic research compound that binds and modulates the nuclear receptors REV-ERBα and REV-ERBβ. It is used in laboratory studies of circadian biology and metabolism, not as an approved medicine. It is also known by the informal name Stenabolic.